Medicare Enrolled
Dr. Jeffrey Mullvain, MD
Cardiovascular Disease · San Diego, CA
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mullvain from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mullvain?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mullvain
Dr. Jeffrey Mullvain is a cardiovascular disease specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mullvain performed 2,976 Medicare services across 2,086 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mullvain received a total of $8,062 from 34 pharmaceutical and/or device companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mullvain is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 36% volume in CA
$8,062 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,976
Medicare services
Top 36% in CA for cardiovascular disease
2,086
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~157 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
762 | $94 | $136 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
532 | $12 | $54 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
281 | $168 | $588 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
226 | $60 | $94 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
119 | $145 | $192 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
116 | $20 | $56 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
104 | $20 | $38 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
102 | $24 | $49 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
84 | $65 | $121 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
83 | $21 | $82 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
83 | $781 | $1,298 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
56 | $26 | $79 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $107 | $206 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
43 | $22 | $182 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
43 | $201 | $451 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
42 | $45 | $150 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
37 | $170 | $318 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
35 | $64 | $87 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $21 | $32 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $98 | $157 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
23 | $16 | $51 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
21 | $10 | $53 |
| New patient office visit, complex (60-74 min) | 21 | $163 | $251 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
20 | $49 | $174 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $143 | $254 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
17 | $58 | $289 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.4% high complexity
7.5% medium
73.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,062
Total received (2018-2024)
Avg $1,152/year across 7 years
Top 31% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
397
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,982 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$712
2023
$892
2022
$261
2021
$544
2020
$509
2019
$2,448
2018
$2,697
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$153
Medtronic, Inc.
$102
E.R. Squibb & Sons, L.L.C.
$94
Amgen Inc.
$78
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Novo Nordisk Inc
$47
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$43
Kiniksa Pharmaceuticals International, plc
$41
Bayer Healthcare Pharmaceuticals Inc.
$33
PFIZER INC.
$26
Abbott Laboratories
$21
Esperion Therapeutics, Inc.
$18
Top 3 companies account for 49.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,950
PFIZER INC.
$944
Amgen Inc.
$926
Janssen Pharmaceuticals, Inc
$445
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$409
Abbott Laboratories
$356
E.R. Squibb & Sons, L.L.C.
$342
SANOFI-AVENTIS U.S. LLC
$340
Amarin Pharma Inc.
$222
Allergan Inc.
$209
GlaxoSmithKline, LLC.
$195
AstraZeneca Pharmaceuticals LP
$182
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
Medtronic, Inc.
$175
Philips Electronics North America Corporation
$159
Regeneron Healthcare Solutions, Inc.
$146
Medtronic Vascular, Inc.
$125
Actelion Pharmaceuticals US, Inc.
$104
Novo Nordisk Inc
$88
iRhythm Technologies, Inc.
$76
BIOTRONIK INC.
$76
Gilead Sciences, Inc.
$73
Boston Scientific Corporation
$64
Kowa Pharmaceuticals America, Inc.
$46
Kiniksa Pharmaceuticals International, plc
$41
Bayer Healthcare Pharmaceuticals Inc.
$33
BOSTON SCIENTIFIC CORPORATION
$27
Radius Health, Inc.
$25
Sunovion Pharmaceuticals Inc.
$23
Noden Pharma USA Inc
$20
W. L. Gore & Associates, Inc.
$19
Esperion Therapeutics, Inc.
$18
Lilly USA, LLC
$14
Daiichi Sankyo Inc.
$13
Top 3 companies account for 47.4% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ANORO · AURORA EV-ICD MRI SURESCAN · Aimovig · Arcalyst · Azure · BASAGLAR · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · CONFIRM RX · CardioMEMS HF System · Confirm Rx · Connect HF · Corlanor · ELIQUIS · ENTRESTO · GENERAL BRADY · GENERAL - BRADY · INJECTAFER · JARDIANCE · JOT DX · Kerendia · LATITUDE · LEQVIO · LINQ II · LUX-DX · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · NEXLETOL · Norditropin · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PERCEPTA QUAD CRT-P MRI SURESCAN · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · Repatha · Respiratoriy Care Undiv · Reveal LINQ · Rybelsus · SHINGRIX · TEFLARO · TEKTURNA · TRELEGY ELLIPTA · Tresiba · Trilogy 100 · Tymlos · UPTRAVI · UTIBRON · VYNDAQEL · Vascepa · Wellcentive Undiv · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
239
Per 100K population
7.3
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mullvain is an electrophysiology & remote specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mullvain experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mullvain performed 762 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mullvain receive payments from pharmaceutical companies?
Yes. Dr. Mullvain received a total of $8,062 from 34 companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mullvain's costs compare to other cardiologists in San Diego?
Dr. Mullvain's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mullvain) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Diego
Browse cardiologists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology